相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PHYOX2: a pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2
Michelle A. Baum et al.
KIDNEY INTERNATIONAL (2023)
Healthcare utilization, quality of life, and work productivity associated with primary hyperoxaluria: a cross-sectional web-based US survey
David S. Goldfarb et al.
UROLITHIASIS (2023)
Perspectives in primary hyperoxaluria - historical, current and future clinical interventions
Kevin Shee et al.
NATURE REVIEWS UROLOGY (2022)
Clinical characterization of primary hyperoxaluria type 3 in comparison with types 1 and 2
Prince Singh et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)
Primary Hyperoxaluria Type 3 Can Also Result in Kidney Failure: A Case Report
Prince Singh et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2022)
Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluria
Bernd Hoppe et al.
KIDNEY INTERNATIONAL (2022)
A report from the European Hyperoxaluria Consortium (OxalEurope) Registry on a large cohort of patients with primary hyperoxaluria type 3
Cristina Martin-Higueras et al.
KIDNEY INTERNATIONAL (2021)
End Points for Clinical Trials in Primary Hyperoxaluria
Dawn S. Milliner et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Primary Hyperoxaluria The Patient and Caregiver Perspective
Jennifer E. Lawrence et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Reduction in urinary oxalate excretion in mouse models of Primary Hyperoxaluria by RNA interference inhibition of liver lactate dehydrogenase activity
Kyle D. Wood et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
Nine novel HOGA1 gene mutations identified in primary hyperoxaluria type 3 and distinct clinical and biochemical characteristics in Chinese children
Xiaoliang Fang et al.
PEDIATRIC NEPHROLOGY (2019)
Mutation Hot Spot Region in the HOGA1 Gene Associated with Primary Hyperoxaluria Type 3 in the Chinese Population
Wenying Wang et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2019)
Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria
Chengjung Lai et al.
MOLECULAR THERAPY (2018)
Metabolic profile and impact of diet in patients with primary hyperoxaluria
Roswitha Siener et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2018)
Predictors of Incident ESRD among Patients with Primary Hyperoxaluria Presenting Prior to Kidney Failure
Fang Zhao et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria
Katharina Hopp et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Renal function can be impaired in children with primary hyperoxaluria type 3
Lise Allard et al.
PEDIATRIC NEPHROLOGY (2015)
Primary Hyperoxaluria
Pierre Cochat et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C
George J. Schwartz et al.
KIDNEY INTERNATIONAL (2012)
An update on primary hyperoxaluria
Bernd Hoppe
NATURE REVIEWS NEPHROLOGY (2012)
Primary Hyperoxaluria Type III Gene HOGA1 (Formerly DHDPSL) as a Possible Risk Factor for Idiopathic Calcium Oxalate Urolithiasis
Carla G. Monico et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Mutations in DHDPSL Are Responsible For Primary Hyperoxaluria Type III
Ruth Belostotsky et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2010)
Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and Better Risk Predictions
Andrew S. Levey et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
分享论文
